http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-101367-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
filingDate 2009-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84b64625dcf0f10afa442162dbe774e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ddec790cfa3c5a83bd15d4767fd4574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47f0fdbc4a56688e145009eb57f30bf6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba9997e9c23130529e61dcc721048262
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ccb7a94bc94271916c58a0c49bb33a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68dddfd23c58c9e09bd17d8a7ab4b0e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dacc3c3159b5ddd6235dd86913b5b7a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59e20f59d2f0a597ceea2f2d21d51d57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24c1aa9d737b78decdd2a944cd765ea0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cfb2ec42b98106b54c708d8399a3b3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94d1fa77924e9908f1624fbc3ec29346
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e6fd5fa94c327d7c97d75e66704fbe9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f9f36d7b94dba98bb1216cc4cd6e750
publicationDate 2013-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UA-101367-C2
titleOfInvention HYDROXYMETHYLPYROLYDINES AS AGRONISTS OF ADRENERGIC β3 RECEPTORS [Normal; heading 1; heading 2; heading 3;
abstract This invention relates to compounds of formula (Ia), pharmaceutical compositions with the compounds and their use in the treatment or prevention of diseases mediated by β3 adrenoreceptor activation.
priorityDate 2008-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID155
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID430991
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517041
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551550
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281606
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11556
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID699129
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID442979
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID464113
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31268
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25645

Total number of triples: 41.